Concepedia

L. Moureau-Zabotto

LM

3

Publications

252

Citations

3

H-Index

2005

Active since

Affiliations

Institut Paoli-Calmettes(Current)

L. Moureau-Zabotto is an author at Institut Paoli-Calmettes specializing in radiation oncology, health sciences, and medicine.

Top concepts

Publications per year

2005–2012

3

Publications

3

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Anthony Gonçalvès, Marine Gilabert, E. François et al. · Annals of Oncology · 2012 · 213 citations · Full text

, , +9

Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer

L. Moureau-Zabotto, C. Bouchet, D. Cesari et al. · Breast Cancer Research and Treatment · 2005 · 29 citations

, , +11

BAYPAN study: A double-blind, phase III randomized trial of gemcitabine plus sorafenib versus gemcitabine plus placebo in patients with advanced pancreatic cancer.

Anthony Gonçalvès, F. Viret, Éric François et al. · Journal of Clinical Oncology · 2011 · 10 citations

, , +19

Rows per page

1–3 of 3